Covid-19 drug treatment evaluated by EMA & Dutch regulator

A name brand version of a cheap and widely available anti-inflammatory steroid will be assessed by the European Medicines Agency (EMA) to determine if it can be recommended as a treatment option for adult patients suffering from Covid-19. The EMA said on Wednesday it would evaluate the drug, Dexamethasone Taw, using an accelerated procedure which will take 150 days instead of 210.Submitted by Zack Newmark on Thursday, 3 September 2020 - 14:30 https://nltimes.nl/2020/09/03/covid-19-drug-treatment-evaluated-ema-dutch-regulator